RGEN FY 2025 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$738M+16.4% YoY

Gross Profit

$348M47.1% margin

Operating Income

$60M8.1% margin

Net Income

$49M6.6% margin

EPS (Diluted)

$0.86

Cash Flow

Operating Cash Flow

$117M

Free Cash Flow

$94M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$844M

Stockholders' Equity

$2.1B

Cash & Equivalents

$566M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$738M	$634M	+16.4%
Gross Profit	$348M	$275M	+26.6%
Operating Income	$60M	-$35M	+269.7%
Net Income	$49M	-$26M	+291.6%